A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors

Key facts

Sponsor

Medical University of South Carolina

Principal Investigator

B. Joseph Elmunzer

Medical University of South Carolina

Intervention

PTBD(procedure)

Enrollment

13 enrolled

Eligibility

40 years · All sexes

Timeline

2017 – 2019

Study locations (25)

• University of Southern California, Los Angeles, California, United States
• Cedars Sinai Medical Center, Los Angeles, California, United States
• Yale University, New Haven, Connecticut, United States
• Sibley Memorial Hospital, Washington D.C., District of Columbia, United States
• University of Florida, Gainesville, Florida, United States
• University of Florida - Jacksonville, Jacksonville, Florida, United States
• Borland-Groover Clinic, Jacksonville, Florida, United States
• Emory University, Atlanta, Georgia, United States
• Northwestern University, Chicago, Illinois, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• Boston University, Boston, Massachusetts, United States
• University of Michigan, Ann Arbor, Michigan, United States
• Saint Louis University, St Louis, Missouri, United States
• Washington University, St Louis, Missouri, United States
• Dartmouth University, Lebanon, New Hampshire, United States
• +10 more locations on ClinicalTrials.gov

Collaborators

Yale University · Virginia Commonwealth University · Vanderbilt University · Stony Brook University · University of Southern California · Case Western Reserve University · Medical College of Wisconsin · Dartmouth University · University of Florida · Northwestern University · Johns Hopkins University · Washington University School of Medicine · University of Michigan · Boston University · Ohio State University · Borland-Groover Clinic · Methodist Health System · St. Louis University · Fox Chase Cancer Center · Emory University · Cedars-Sinai Medical Center · Johns Hopkins Community Physicians · University of Virginia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Perihilar cholangiocarcinoma

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06986486
  Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
• RECRUITINGNANCT06850753
  En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria
  Oslo University Hospital
• ACTIVE NOT RECRUITINGPHASE2NCT06717464
  Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
  Tianjin Medical University Cancer Institute and Hospital
• RECRUITINGNANCT06493734
  Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma
  Erasmus Medical Center
• ACTIVE NOT RECRUITINGPHASE2NCT05564403
  Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)
  National Cancer Institute (NCI)
• ACTIVE NOT RECRUITINGPHASE2NCT06178588
  Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
  University of Kansas Medical Center
• RECRUITINGNANCT06125769
  LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)
  Azienda Sanitaria Ospedaliera
• RECRUITINGPHASE4NCT05551299
  Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
  University of Leipzig

See all trials for Perihilar cholangiocarcinoma →